[1]
O. Putrawan and I. P. Sri Rejeki, “AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN”, FMI, vol. 51, no. 3, pp. 187–189, Nov. 2016.